Difference between revisions of "Category:Graft versus host disease medications"

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search
(Created page with "Medications used to treat the symptoms of graft versus host disease (GVHD). Ibrutinib (Imbruvica) is the only currently ''FDA-approved'' therapy for the treatment of c...")
 
m
 
(3 intermediate revisions by 2 users not shown)
Line 1: Line 1:
Medications used to treat the symptoms of [[graft versus host disease (GVHD)]]. [[Ibrutinib (Imbruvica)]] is the only currently ''FDA-approved'' therapy for the treatment of chronic GVHD.
+
Medications used to treat the symptoms of [[graft versus host disease (GVHD)]].

Latest revision as of 22:58, 30 May 2019

Medications used to treat the symptoms of graft versus host disease (GVHD).

Subcategories

This category has only the following subcategory.